Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 2Tumor-Agnostic 1Thoracic 1Other solid neoplasm 1Gynecologic 1

Conditions

Breast Neoplasms 2Ovarian Neoplasms 1

Interventions

Cyclophosphamide 89Capecitabine 88Trastuzumab 81Docetaxel 81Paclitaxel 65Epirubicin 57pyrotinib 55Tamoxifen 54Letrozole 53Fulvestrant 49Vinorelbine 43Carboplatin 43Doxorubicin 41Radiotherapy 33Anastrozole 32exemestane 31Neoadjuvant Therapy 29palbociclib 27Drug Therapy 27Fluorouracil 24Bevacizumab 24pertuzumab 23Cisplatin 23eribulin 22Exercise 21130-nm albumin-bound paclitaxel 21Goserelin 20Gemcitabine 20Chemotherapy, Adjuvant 19Albumin-Bound Paclitaxel 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × High-Throughput Nucleotide Sequencing × Breast × Clear all
NCT05763472 2023-03-10

Gen-eva

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Unknown
10 enrolled
BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms

NCT04996836 2021-08-13

BR(E)2ASTOME

University of Campania Luigi Vanvitelli

Phase 2 Unknown
200 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡